NAEJA PHARMACEUTICAL INC. RECEIVES $10 MILLION BOOST FOR DRUG DISCOVERY

NAEJA Pharmaceutical Inc., an Edmonton-based company, is being given the opportunity to help discover the next innovative medicine for pain control after receiving a significant investment from AstraZeneca Canada. Under the terms of the deal announced today, AstraZeneca Canada will invest $10.2 million over the three-year partnership that will create 20 new jobs at NAEJA, and focus on accelerating the development of novel pain control compounds. Eworldwire (http://newsroom.eworldwire.com/view_release.php?id=13994)